Acinetobacter species, particularly Acinetobacter baumannii, is the first pathogen on the
critical priority list of pathogens for novel antibiotics to become a “red-alert” human …

The COVID-19 pandemic has generated an overuse of antimicrobials in critically ill patients.
Acinetobacter baumannii frequently causes nosocomial infections, particularly in intensive …

Acinetobacter baumannii (A. baumannii) is a leading cause of nosocomial infections as this
pathogen has certain attributes that facilitate the subversion of natural defenses of the …

Acinetobacter baumannii is increasingly associated with various epidemics, representing a
serious concern due to the broad level of antimicrobial resistance and clinical …

Objectives A. baumannii is considered as a “red alert” nosocomial human pathogen and
exhibits an extensive antibiotic resistance spectrum. The biofilm formation mediated by the …

Multidrug resistant Acinetobacter baumannii is a serious healthcare threat. In fact, the Center
for Disease Control recently reported that carbapenem-resistant A. baumannii is responsible …

Bacterial biofilms are a serious public-health problem worldwide. In recent years, the rates of
antibiotic-resistant Gram-negative bacteria associated with biofilm-forming activity have …

Acinetobacter baumannii has notably become a superbug due to its mounting risk of
infection and escalating rates of antimicrobial resistance, including colistin, the last-resort …

Acinetobacter baumannii is an opportunistic pathogen which is undoubtedly known for a
high rate of morbidity and mortality in hospital-acquired infections. A. baumannii causes life …

Bacterial infection by ESKAPE (Enterococcus faecium, Staphylococcus aureus, Klebsiella
pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, Enterobacter spp.) …